Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KALV

KalVista

$24.70

0.63 (2.62%)

09:16
05/15/19
05/15
09:16
05/15/19
09:16
Recommendations
KalVista analyst commentary at Roth Capital »

KalVista price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
TAK

Takeda Pharmaceutical

$17.88

-0.6 (-3.25%)

, BCRX

BioCryst

$7.89

0.19 (2.47%)

12:25
04/18/19
04/18
12:25
04/18/19
12:25
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

TAK

Takeda Pharmaceutical

$17.88

-0.6 (-3.25%)

BCRX

BioCryst

$7.89

0.19 (2.47%)

KALV

KalVista

$24.82

-0.58 (-2.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 24

    Apr

TAK

Takeda Pharmaceutical

$18.48

-0.485 (-2.56%)

, BCRX

BioCryst

$7.70

-0.65 (-7.78%)

04:55
04/18/19
04/18
04:55
04/18/19
04:55
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

TAK

Takeda Pharmaceutical

$18.48

-0.485 (-2.56%)

BCRX

BioCryst

$7.70

-0.65 (-7.78%)

KALV

KalVista

$25.40

0.26 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 24

    Apr

TAK

Takeda Pharmaceutical

$19.03

-0.48 (-2.46%)

, BCRX

BioCryst

$8.53

-0.23 (-2.63%)

16:41
04/12/19
04/12
16:41
04/12/19
16:41
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts…

TAK

Takeda Pharmaceutical

$19.03

-0.48 (-2.46%)

BCRX

BioCryst

$8.53

-0.23 (-2.63%)

KALV

KalVista

$25.99

-0.56 (-2.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

LYFT

Lyft

$0.00

(0.00%)

, KALV

KalVista

$29.20

0.85 (3.00%)

10:00
03/20/19
03/20
10:00
03/20/19
10:00
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

LYFT

Lyft

$0.00

(0.00%)

KALV

KalVista

$29.20

0.85 (3.00%)

BTU

Peabody Energy

$29.88

-0.11 (-0.37%)

FOXA

Fox Corp.

$39.18

-1.21 (-3.00%)

NGHC

National General

$24.24

-0.09 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 29

    Mar

KALV

KalVista

$28.35

2.05 (7.79%)

07:05
03/20/19
03/20
07:05
03/20/19
07:05
Initiation
KalVista initiated at Needham »

KalVista initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$26.22

2.36 (9.89%)

07:32
03/14/19
03/14
07:32
03/14/19
07:32
Earnings
KalVista reports Q4 EPS (23c), consensus (45c) »

Reports Q4 revenue $3.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$20.74

-0.04 (-0.19%)

07:48
02/25/19
02/25
07:48
02/25/19
07:48
Hot Stocks
KalVista presents KVD900 data at AAAAI annual meeting »

KalVista Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$23.70

0.73 (3.18%)

, AZN

AstraZeneca

$40.95

0.515 (1.27%)

04:55
02/25/19
02/25
04:55
02/25/19
04:55
Conference/Events
The American Academy of Asthma, Allergy & Immunology to hold annual meeting »

AAAAI Annual Meeting 2019…

AIMT

Aimmune

$23.70

0.73 (3.18%)

AZN

AstraZeneca

$40.95

0.515 (1.27%)

TEVA

Teva

$17.28

0.03 (0.17%)

NVS

Novartis

$90.77

0.26 (0.29%)

DNA

Bought by RHHBY

$0.00

(0.00%)

SHPG

Shire

$0.00

(0.00%)

REGN

Regeneron

$422.43

3.77 (0.90%)

SNY

Sanofi

$41.20

-0.13 (-0.31%)

ALK

Alaska Air

$62.35

-0.48 (-0.76%)

ABT

Abbott

$76.40

1.26 (1.68%)

CVS

CVS Health

$62.00

-0.33 (-0.53%)

KALV

KalVista

$20.74

-0.04 (-0.19%)

BCRX

BioCryst

$8.99

0.32 (3.69%)

OPTN

Optinose

$7.31

0.02 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

  • 07

    Mar

  • 11

    Mar

  • 12

    Mar

  • 18

    Mar

  • 19

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

  • 18

    May

AIMT

Aimmune

$23.70

0.73 (3.18%)

, AZN

AstraZeneca

$40.95

0.515 (1.27%)

04:55
02/24/19
02/24
04:55
02/24/19
04:55
Conference/Events
The American Academy of Asthma, Allergy & Immunology to hold annual meeting »

AAAAI Annual Meeting 2019…

AIMT

Aimmune

$23.70

0.73 (3.18%)

AZN

AstraZeneca

$40.95

0.515 (1.27%)

TEVA

Teva

$17.28

0.03 (0.17%)

NVS

Novartis

$90.77

0.26 (0.29%)

DNA

Bought by RHHBY

$0.00

(0.00%)

SHPG

Shire

$0.00

(0.00%)

REGN

Regeneron

$422.43

3.77 (0.90%)

SNY

Sanofi

$41.20

-0.13 (-0.31%)

ALK

Alaska Air

$62.35

-0.48 (-0.76%)

ABT

Abbott

$76.40

1.26 (1.68%)

CVS

CVS Health

$62.00

-0.33 (-0.53%)

KALV

KalVista

$20.74

-0.04 (-0.19%)

BCRX

BioCryst

$8.99

0.32 (3.69%)

OPTN

Optinose

$7.31

0.02 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

  • 07

    Mar

  • 11

    Mar

  • 12

    Mar

  • 18

    Mar

  • 19

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.